Skip to content

Different minimally invasive surgery (MIS) in the treatment of spontaneous supratentorial intracranial hemorrhage

Different minimally invasive surgery (MIS) in the treatment of spontaneous supratentorial intracranial hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046818
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spontaneous supratentorial intracranial hemorrhage

Interventions

Stereotactic hematoma puncture plus urokinase thrombolysis group:Stereotactic hematoma puncture plus urokinase thrombolysis
Neuroendoscopic surgery group:Neuroendoscopic surgery
Small bone window minimally invasive surgery group:Small bone window minimally invasive surgery

Sponsors

The First Affiliated Hospital Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. CT or MRI confirmed spontaneous supratentorial ICH; 2. The volume of hematoma was 30-60ml; 3. Glasgow Coma Scale: 5-14 points; 4. The modified Rankin Scale (MRS) score was 0 or 1 before bleeding; 5. The subjects and their families knew about the clinical trial protocol and agreed to participate in the trial; 6. Age of eligible patients: 18-75 years old; 7. NIHSS score >= 6.

Exclusion criteria

Exclusion criteria: 1. Traumatic intracranial hemorrhage; 2. Coagulation dysfunction, such as thrombocytopenia or hepatitis, etc; 3. Severe heart, liver, kidney and lung diseases or functional failure were found; 4. Suspected cavernous malformation, aneurysm, arteriovenous malformation, moyamoya disease, subarachnoid hemorrhage and tumor stroke were found on CT and MRI; 5. Infratentorial intracerebral hemorrhage, including cerebellar hemorrhage or brainstem hemorrhage; 6. Multiple supratentorial intracranial hematomas; 7. A history of stroke with neurological dysfunction; 8. Cases considered unsuitable for inclusion by the researchers.

Design outcomes

Secondary

MeasureTime frame
modified rankin scale score;Barthe index (BI);NIH Strke Scale, NIHSS;

Primary

MeasureTime frame
Glasgow Coma Scale;

Countries

China

Contacts

Public ContactWang Jianjun

The First Affiliated Hospital Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)

1499@sdhospital.com.cn+86 13964115460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026